As a final analysis, we focused on one of the elucidated novel NAT-tumour connections, of NAA40 with liver cancer, for three main reasons: (i) the upregulation of NAA40 in liver cancer tissue compared to normal tissue (Figure 3A), (ii) the correlation between high NAA40 transcript levels and worst survival of liver cancer patients (Table 1), and (iii) a previous report that links NAA40 to hepatic steatosis [31]. The gene discussed is NAA40; the disease is neoplasm.